Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Dr.Reddy's Laboratories Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Jun 2016 Reuters Investment Profile 12 $20.00

Dr.Reddy's Laboratories Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

25 Jun 2016 Reuters Investment Profile 12 $20.00

ValuEngine Rating and Forecast Report for RDY

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

26 Jun 2016 ValuEngine, Inc. 11 $25.00

DR REDDY S LABORATORIES INC (RDY=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

25 Jun 2016 Pechala's Reports 2 $25.00

Thomson Reuters Stock Report - Dr.Reddy's Laboratories Ltd (DRREDDY-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

24 Jun 2016 Thomson Reuters Stock Report 11 $25.00

Value Graph: DR REDDY'S LAB -- RDY

24 Jun 2016 Ford Investor Services, Inc. 1 $12.00

Dr.Reddy's Laboratories Ltd (ADR): Upgraded to Above Average

22 Jun 2016 Sadif Analytics Prime 3 $10.00

Validea Guru Analysis Report for RDY. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.

Validea's Guru Stock Report uses an interpretation of the published stock-picking strategies developed by 10 investing legend...

17 Jun 2016 Validea 0 $12.00

MOSL: DR REDDY’ S LABS (Neutral)-Announces acquisition of ANDA portfolio from Teva

DR REDDY’ S LABS: Announces acquisition of ANDA portfolio from Teva (DRRD IN, Mkt Cap USD7.8b, CMP INR3086, TP INR3200, 4% U...

14 Jun 2016 Motilal Oswal Securities Ltd. 8 $58.00

Dr. Reddy's Laboratories Limited (DRREDDY) - Financial and Strategic SWOT Analysis Review

Dr. Reddy's Laboratories Limited (DRREDDY) - Financial and Strategic SWOT Analysis Review Summary Dr. Reddy's Laboratories Li...

06 Jun 2016 GlobalData 126 $300.00